Frontiers in Immunology | Cancer Immunity and Immunotherapy

Original Research

Accepted on 19 Feb 2025

TMED9: A Potential Therapeutic Target and Prognostic Marker in Glioma and Its Implications Across Pan-Cancer Contexts

in Cancer Immunity and Immunotherapy

Benyong Mi
Chaolin Li

Frontiers in Immunology

doi 10.3389/fimmu.2025.1558881

Review

Published on 19 Feb 2025

Expanding the horizon of CAR T cell therapy: from cancer treatment to autoimmune diseases and beyond

in Cancer Immunity and Immunotherapy

Zishan Yang
Bingjun Ha
Qinhan Wu
Feng Ren
Zhinan Yin
Hongru Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1544532

217 views

Original Research

Published on 19 Feb 2025

A novel glycolysis-related gene signature for predicting prognosis and immunotherapy efficacy in breast cancer

in Cancer Immunity and Immunotherapy

Rui Huang
Yi Li
Kaige Lin
Luming Zheng
Xiaoru Zhu
Leqiu Huang
Yunhan Ma

Frontiers in Immunology

doi 10.3389/fimmu.2025.1512859

133 views

Original Research

Accepted on 18 Feb 2025

AI-enhanced profiling of phage-display-identified anti-TIM3 and anti-TIGIT novel antibodies

in Cancer Immunity and Immunotherapy

Astrid Musnier
Yannick Corde
Adrien Verdier
Mélanie Cortes
Christophe Dumet
Jean-René Pallandre
Adeline Bouard
Abdelraouf Keskes
Zakaria Omahdi
Vincent Puard

Frontiers in Immunology

doi 10.3389/fimmu.2025.1499810

Original Research

Accepted on 18 Feb 2025

Integrative Analysis of Single-Cell and Bulk RNA Sequencing Reveals the Oncogenic Role of ANXA5 in Gastric Cancer and Its Association with Drug Resistance

in Cancer Immunity and Immunotherapy

Denggang Chen
Peng Zhang
Li Gong
Hailang Wei
Chen Bai
Tingting Zhang
Guanghui Yu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1562395

Original Research

Accepted on 18 Feb 2025

Camrelizumab-based therapies for the treatment of advanced lung cancer: a prospective, open-label, multicenter, observational, real-world study

in Cancer Immunity and Immunotherapy

Dong Zhao
Minghong Bi
Xiaofei Cheng
Shuhong Wang
Huaidong Cheng
Xiaoyang Xia
Huan Chen
Yanbei Zhang
Zhiqiang Hu
Qisheng Cao

Frontiers in Immunology

doi 10.3389/fimmu.2025.1494708

Review

Accepted on 18 Feb 2025

CD19 -targeted CAR T therapy treating Hematologic malignancies：hidden danger is the next neighbor to security？

in Cancer Immunity and Immunotherapy

学帅叶
min ge
mengtian tan
yongqiang wu
haiqiang zhang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1490491

Original Research

Published on 18 Feb 2025

Similarities and differences of a proliferation-inducing ligand expression in lacrimal gland lesions of patients with IgG4-associated ophthalmic diseases and mucosa-associated lymphoid tissue lymphoma

in Cancer Immunity and Immunotherapy

Lvfu He
Lisha Zhan
Yu Yang
Weimin He

Frontiers in Immunology

doi 10.3389/fimmu.2025.1514003

125 views

Original Research

Published on 18 Feb 2025

AWT020: a novel fusion protein harnessing PD-1 blockade and selective IL-2 Cis-activation for enhanced anti-tumor immunity and diminished toxicity

in Cancer Immunity and Immunotherapy

Fan Ye
Jianing Huang
Xiaoli Cheng
Shih Chieh Chen
Fang Huang
Wen-Chin Huang
Botong Hua
Ella Li
Jenny Jiang
Hanna Lin

Frontiers in Immunology

doi 10.3389/fimmu.2025.1537466

344 views

Brief Research Report

Published on 18 Feb 2025

Follow-up of humoral and cellular immune responses after the third SARS-CoV-2 vaccine dose in multiple myeloma patients

in Cancer Immunity and Immunotherapy

Vincenzo Raimondi
Paola Storti
Rosanna Vescovini
Valentina Franceschi
Denise Toscani
Laura Notarfranchi
Anna Benedetta Dalla Palma
Nicolas Thomas Iannozzi
Sergio Minesso
Matteo Scita

Frontiers in Immunology

doi 10.3389/fimmu.2025.1532947

232 views

Review

Published on 18 Feb 2025

Polyamine metabolism and anti-tumor immunity

in Cancer Immunity and Immunotherapy

Jing-Yi Wu
Yan Zeng
Yu-Yang You
Qi-Yue Chen

Frontiers in Immunology

doi 10.3389/fimmu.2025.1529337

102 views

Case Report

Published on 18 Feb 2025

Combination of cadonilimab (PD-1/CTLA-4 bispecific antibody) and apatinib as salvage therapy achieves partial response in MSI-H advanced gastric cancer: a case report

in Cancer Immunity and Immunotherapy

Jiayu Zhao
Xiaoxiao Li
Xiaoyuan Sun
Ruoxi Xiao
Juan Xue
Kexin Sui
Zimin Liu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1533700

120 views

Mini Review

Published on 18 Feb 2025

Post-translational modifications in hepatocellular carcinoma: unlocking new frontiers in immunotherapy

in Cancer Immunity and Immunotherapy

Yuexian Piao
Naicui Zhai
Xiaoling Zhang
Wenjie Zhao
Min Li

Frontiers in Immunology

doi 10.3389/fimmu.2025.1554372

113 views

Original Research

Published on 18 Feb 2025

Predictors of severity and onset timing of immune-related adverse events in cancer patients receiving immune checkpoint inhibitors: a retrospective analysis

in Cancer Immunity and Immunotherapy

Qimei Fang
Yan Qian
Zhaolu Xie
Hongqiong Zhao
Yang Zheng
Di Li

Frontiers in Immunology

doi 10.3389/fimmu.2025.1508512

132 views

Review

Published on 18 Feb 2025

New hopes and challenges in targeted therapy and immunotherapy for primary central nervous system lymphoma

in Cancer Immunity and Immunotherapy

Chuanwei Yang
Xiaohui Ren
Yong Cui
Haihui Jiang
Ming Li
Kefu Yu
Shaoping Shen
Mingxiao Li
Xiaokang Zhang
Xuzhe Zhao

Frontiers in Immunology

doi 10.3389/fimmu.2025.1438001

110 views

Original Research

Published on 18 Feb 2025

High-dose radiation induces dendritic cells maturation by promoting immunogenic cell death in nasopharyngeal carcinoma

in Cancer Immunity and Immunotherapy

Xianlin Zeng
Xianhuai Jin
Ji Leng
Shuai Zhang
Yun Wang
Jin Chen
Shichao Zhang
Lijing Teng
Zuquan Hu
Shi Zhou

Frontiers in Immunology

doi 10.3389/fimmu.2025.1554018

164 views

Navigation group

Articles

TMED9: A Potential Therapeutic Target and Prognostic Marker in Glioma and Its Implications Across Pan-Cancer Contexts

Expanding the horizon of CAR T cell therapy: from cancer treatment to autoimmune diseases and beyond

A novel glycolysis-related gene signature for predicting prognosis and immunotherapy efficacy in breast cancer

AI-enhanced profiling of phage-display-identified anti-TIM3 and anti-TIGIT novel antibodies

Integrative Analysis of Single-Cell and Bulk RNA Sequencing Reveals the Oncogenic Role of ANXA5 in Gastric Cancer and Its Association with Drug Resistance

Camrelizumab-based therapies for the treatment of advanced lung cancer: a prospective, open-label, multicenter, observational, real-world study

CD19 -targeted CAR T therapy treating Hematologic malignancies：hidden danger is the next neighbor to security？

Similarities and differences of a proliferation-inducing ligand expression in lacrimal gland lesions of patients with IgG4-associated ophthalmic diseases and mucosa-associated lymphoid tissue lymphoma

AWT020: a novel fusion protein harnessing PD-1 blockade and selective IL-2 Cis-activation for enhanced anti-tumor immunity and diminished toxicity

Follow-up of humoral and cellular immune responses after the third SARS-CoV-2 vaccine dose in multiple myeloma patients

Polyamine metabolism and anti-tumor immunity

Combination of cadonilimab (PD-1/CTLA-4 bispecific antibody) and apatinib as salvage therapy achieves partial response in MSI-H advanced gastric cancer: a case report

Post-translational modifications in hepatocellular carcinoma: unlocking new frontiers in immunotherapy

Predictors of severity and onset timing of immune-related adverse events in cancer patients receiving immune checkpoint inhibitors: a retrospective analysis

New hopes and challenges in targeted therapy and immunotherapy for primary central nervous system lymphoma

High-dose radiation induces dendritic cells maturation by promoting immunogenic cell death in nasopharyngeal carcinoma